印度首季智能手機出貨量增26% 小米(01810.HK)出貨量升5%市佔居首
調查機構Strategy Analytics發表的報告指,今年首季印度智能手機出貨量按年增26%至3,900萬台,是六年以來最高增速,主要受惠當地封城措施首季暫時放寬,加上對新的4G手機需求上升。
按品牌劃分,小米(01810.HK)市佔率27%排名第一,出貨量按年增5%至1,030萬台,該行的分析指出其市佔率自高位回落,同時在當地亦面對三星及Vivo的競爭,期內三星出貨量排第二,按年增45%至720萬台,Vivo則排第三,出貨量按年增46%至700萬台。
分析認為雖然首季當地智能手機需求強勁,但估計次季將有所回落,主要因為當地確診個案急增、封城措施再度收緊,相信當地智能手機市場仍然十分波動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.